PatrickScottColemanMD
Cardiology • Boise, IDAdult Congenital Heart Disease, Cardiac Electrophysiology, Interventional Cardiology
Physician
Are you Dr. Coleman?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 114 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
6140 W Curtisian Ave Ste 200
6140 W Curtisian Ave Ste 200
Boise, ID 83704Phone+1 208-302-0000Fax+1 208-302-0055
Summary
- Dr. Patrick Coleman, MD is a cardiologist in Boise, Idaho. He is currently licensed to practice medicine in Idaho, Oregon, and California. He is affiliated with Saint Alphonsus Regional Medical Center.
Education & Training
Tufts Medical CenterFellowship, Cardiovascular Disease, 1989 - 1992
McGaw Medical Center of Northwestern UniversityFellowship, Cardiovascular Disease, 1987 - 1989- McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1984 - 1987
- Northwestern University The Feinberg School of MedicineClass of 1984
Certifications & Licensure
CA State Medical License 1992 - 2026
ID State Medical License 2020 - 2025
OR State Medical License 2020 - 2025
IL State Medical License 1984 - 1990- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Atlanta Magazine: Top Doctors Castle Connolly, 2011-2014
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 58 citationsThe “Final” 5-Year Follow-Up From the ENDEAVOR IV Trial Comparing a Zotarolimus-Eluting Stent With a Paclitaxel-Eluting StentAjay J. Kirtane, Martin B. Leon, Michael W. Ball, Harpaul S. Bajwa, Michael H. Sketch
JACC. Cardiovascular Interventions. 2013-04-01 - 124 citationsTwo-Year Outcomes After Sirolimus-Eluting Stent Implantation: Results From the Sirolimus-Eluting Stent in de Novo Native Coronary Lesions (SIRIUS) TrialGiora Weisz, Martin B. Leon, David R. Holmes, Dean J. Kereiakes, Mel R. Clark
Journal of the American College of Cardiology. 2006-04-04 - 48 citationsRandomized, Controlled Dose-Ranging Study of the Selective Adenosine A2A Receptor Agonist Binodenoson for Pharmacological Stress as an Adjunct to Myocardial Perfusion ...James E. Udelson, Gary V. Heller, Frans J. Th. Wackers, Andrew Chai, David A Hinchman
Circulation. 2004-02-03
Press Mentions
NCMA Primary Care Spring Symposium Educational Videos Now Offered OnlineApril 21st, 2017
Professional Memberships
- Member
